Intended for contraception and premenstrual dysphoric disorder to manage reproductive cycles and support pregnancy prevention.
Mechanism of Action
This combination prevents pregnancy primarily by inhibiting ovulation. Drospirenone also has antimineralocorticoid properties that help reduce water retention and manage hormonal acne symptoms.
Route of Administration
Oral
Onset Time
1–3 days
Duration
24 hours
Contraindications
Renal impairment, Adrenal insufficiency, History of thromboembolism, Breast cancer
Severe Adverse Events
Deep vein thrombosis, Pulmonary embolism, Hyperkalemia — requires immediate medical attention
Common Side Effects
Nausea, Breast tenderness, Headache
Uncommon Side Effects
Mood changes, Weight gain, Irregular menstrual bleeding
Information related to Drospirenone with Ethinyl Estradiol is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
